IGF ADVANCED DEVELOPMENT OF CEFTOBIPROLE
Key facts
| Status | Awarded |
|---|---|
| Estimated value | $108,445,186.87 |
| Submission deadline | Deadline not published |
| Published | Apr 19, 2016 |
| Buyer | Office of Assistant Secretary for Preparedness and Response |
| Country | United States |
| CPV code | NAICS 541711 (RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY) · PSC AN13 |
| Source | USAspending.gov Federal Contract Awards ↗ |
- Status
- Awarded
- Estimated value
- $108,445,186.87
- Submission deadline
- Deadline not published
- Published
- Apr 19, 2016
- Country
- United States
- CPV code
- NAICS 541711 (RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY) · PSC AN13
- Source
- USAspending.gov Federal Contract Awards
Contract outcome & evergreen alternatives
This notice is no longer open for submissions. The original remains available for reference.
| Awarded supplier / winner | Registration / LEI number | Country | Awarded contract amount | Award date |
|---|---|---|---|---|
| BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL | US-UEI: UA43HWRNXFS3 | United States | $108,445,186.87 | Apr 19, 2016 |
Checked:
The original notice takes precedence. Its status and conditions can change after collection.
Description
IGF ADVANCED DEVELOPMENT OF CEFTOBIPROLE
Awarding Agency: Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response.
NAICS 541711: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY.
PSC AN13: HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT.
Period of Performance: 2016-04-19 to 2026-04-18.